Cargando…
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review
BACKGROUND: In the US, the approved multiple sclerosis (MS) oral disease-modifying therapies (ODMTs) are fingolimod (FTY), teriflunomide (TFN), and dimethyl fumarate (DMF). FTY and TFN are recommended with once-daily doses with no up-titration, whereas DMF treatment is recommended twice-daily (BID)...
Autores principales: | Nazareth, Tara, Friedman, Howard S., Navaratnam, Prakash, Herriott, Denise A., Ko, John J., Barr, Peri, Sasane, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041514/ https://www.ncbi.nlm.nih.gov/pubmed/27683214 http://dx.doi.org/10.1186/s12883-016-0698-9 |
Ejemplares similares
-
Levodopa treatment patterns in Parkinson’s disease: A retrospective chart review
por: Navaratnam, Prakash, et al.
Publicado: (2022) -
Natural history and patterns of treatment change in Parkinson’s disease: A retrospective chart review
por: Navaratnam, Prakash, et al.
Publicado: (2021) -
Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States
por: Chase, Monica Reed, et al.
Publicado: (2016) -
An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population
por: Johnsrud, Michael, et al.
Publicado: (2021) -
Quality of Co-Prescribing NSAID and Gastroprotective Medications for Elders in The Netherlands and Its Association with the Electronic Medical Record
por: Opondo, Dedan, et al.
Publicado: (2015)